These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 17013093

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.
    Kuźbicki L, Sarnecka A, Chwirot BW.
    Melanoma Res; 2006 Feb; 16(1):29-36. PubMed ID: 16432453
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA, Guitart J, Rao MS, Diaz LK.
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
    Chwirot BW, Kuźbicki Ł.
    Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J, Cronin F, Duncan LM.
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
    Karim RZ, Li W, Sanki A, Colman MH, Yang YH, Thompson JF, Scolyer RA.
    Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of fatty acid synthase (FASN) in oral nevi and melanoma.
    de Andrade BA, León JE, Carlos R, Delgado-Azañero W, Mosqueda-Taylor A, Graner E, de Almeida OP.
    Oral Dis; 2011 Nov; 17(8):808-12. PubMed ID: 21819495
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters.
    Poyraz A, Akyürek N, Gönül II, Erdem O.
    J Exp Clin Cancer Res; 2004 Dec; 23(4):625-31. PubMed ID: 15743033
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.